Albemarle again expands Michigan API plant

Specialty chemicalmaker Albemarle has again expanded its API manufacturing in South Haven, MI. The company, which among other products is a major producer of ibuprofen, says the FDA-registered plant has been expanded and upgraded, the latest in a series of projects to increase production capacity. The Baton Rouge, LA-based company in a release says it is seeing demand grow for both generic APIs and custom products. The South Haven project matched the solids handling equipment with the reactor capacity. The company did not respond to a request for information about the value of the investment. The company in May announced a 15% increase in ibuprofen prices. Release | More

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.